WallStreetZenWallStreetZen

NASDAQ: TIL
Instil Bio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their TIL stock forecasts and price targets.

Forecast return on equity

Is TIL forecast to generate an efficient return?

Company
N/A
Industry
94.37%
Market
175.99%

Forecast return on assets

Is TIL forecast to generate an efficient return on assets?

Company
N/A
Industry
27.62%

TIL earnings per share forecast

What is TIL's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$3.61
Avg 2 year Forecast
-$8.36

TIL revenue forecast

What is TIL's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$0.0

TIL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TIL$7.50N/AN/A
DWTX$1.55$12.00+674.19%Buy
ACTU$2.07$15.00+624.64%Buy
HYPD$3.45$7.30+111.59%Strong Buy
MREO$0.31$1.50+385.44%Buy
View Top Biotech Stocks

Instil Bio Stock Forecast FAQ

What is TIL's earnings growth forecast for 2026-2027?

(NASDAQ: TIL) Instil Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.61%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.05%.

Instil Bio's earnings in 2026 is -$47,376,000.On average, 4 Wall Street analysts forecast TIL's earnings for 2026 to be -$24,476,830, with the lowest TIL earnings forecast at -$49,515,207, and the highest TIL earnings forecast at -$8,331,658.

In 2027, TIL is forecast to generate -$56,716,309 in earnings, with the lowest earnings forecast at -$55,031,666 and the highest earnings forecast at -$58,962,499.

If you're new to stock investing, here's how to buy Instil Bio stock.

What is TIL's revenue growth forecast for 2026-2028?

(NASDAQ: TIL) Instil Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.07%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.06%.

Instil Bio's revenue in 2026 is $0.On average, 3 Wall Street analysts forecast TIL's revenue for 2026 to be $0, with the lowest TIL revenue forecast at $0, and the highest TIL revenue forecast at $0. On average, 2 Wall Street analysts forecast TIL's revenue for 2027 to be $0, with the lowest TIL revenue forecast at $0, and the highest TIL revenue forecast at $0.

In 2028, TIL is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is TIL's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: TIL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 27.62%.

What is TIL's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: TIL) Instil Bio's current Earnings Per Share (EPS) is -$7.04. On average, analysts forecast that TIL's EPS will be -$3.61 for 2026, with the lowest EPS forecast at -$7.30, and the highest EPS forecast at -$1.23. In 2027, TIL's EPS is forecast to hit -$8.36 (min: -$8.11, max: -$8.69).

What is TIL's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: TIL) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.